trending Market Intelligence /marketintelligence/en/news-insights/trending/ccx31n5q25rnwj2oayeypg2 content esgSubNav
In This List

Merck & Co. to create 350 jobs at new manufacturing facility in Ireland

Blog

Insight Weekly: Recession risk persists; Banks pull back from crypto; 2022 laggard stocks rally

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Blog

Insight Weekly: Inflation eases; bank M&A slows; top companies boost market share

Blog

Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet


Merck & Co. to create 350 jobs at new manufacturing facility in Ireland

Merck & Co. Inc. plans to create 350 new jobs by building a biologics manufacturing facility at its Swords site near Dublin, Ireland, FiercePharma reported Feb. 14.

Biologics are large molecules derived from natural sources, such as microorganisms or plant or animal cells.

The company plans to use the new facility to produce its blockbuster cancer drug Keytruda.

Merck expects the plant to be ready by 2021 and start producing commercial products the next year, the news outlet reported.